EcoDrugPlus

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSPFOG00000008171
Gene Symbol: GRM4
1 Cross references
196 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSPFOG00000000190
Gene Symbol: LOC103154056
3 Cross references
250 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSPFOG00000014518
Gene Symbol: LOC103130639
3 Cross references
249 Possible Orthologues:

Glutamate Receptor 3

Ensembl ID : ENSPFOG00000002152
Gene Symbol: LOC103145609
3 Cross references
251 Possible Orthologues:

Glutamate Receptor 4-Like

Ensembl ID : ENSPFOG00000000622
Gene Symbol: LOC103155416
3 Cross references
249 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 1a

Ensembl ID : ENSPFOG00000001085
Gene Symbol: GRIA1A
1 Cross references
244 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSPFOG00000014359
Gene Symbol: GRIN2BB
1 Cross references
250 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSPFOG00000006828
Gene Symbol: GRM5B
1 Cross references
214 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSPFOG00000007688
Gene Symbol: LOC103132169
2 Cross references
232 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSPFOG00000018879
Gene Symbol: LOC103129701
3 Cross references
230 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSPFOG00000007468
Gene Symbol: GSK3B
3 Cross references
222 Possible Orthologues:

Glycogen Synthase Kinase-3 Alpha

Ensembl ID : ENSPFOG00000016170
Gene Symbol: LOC103136805
3 Cross references
186 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).